These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 15655509)

  • 1. Piglet saphenous vein contains multiple relaxatory prostanoid receptors: evidence for EP4, EP2, DP and IP receptor subtypes.
    Wilson RJ; Giles H
    Br J Pharmacol; 2005 Feb; 144(3):405-15. PubMed ID: 15655509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EP4 prostanoid receptor-mediated vasodilatation of human middle cerebral arteries.
    Davis RJ; Murdoch CE; Ali M; Purbrick S; Ravid R; Baxter GS; Tilford N; Sheldrick RL; Clark KL; Coleman RA
    Br J Pharmacol; 2004 Feb; 141(4):580-5. PubMed ID: 14744815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on prostanoid receptors in the rabbit isolated saphenous vein: a comparison with the rabbit isolated ear artery.
    Lydford SJ; McKechnie KC; Dougall IG
    Br J Pharmacol; 1996 Jan; 117(1):13-20. PubMed ID: 8825337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinction between relaxations induced via prostanoid EP(4) and IP(1) receptors in pig and rabbit blood vessels.
    Jones RL; Chan K
    Br J Pharmacol; 2001 Sep; 134(2):313-24. PubMed ID: 11564649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GW627368X ((N-{2-[4-(4,9-diethoxy-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl)phenyl]acetyl} benzene sulphonamide): a novel, potent and selective prostanoid EP4 receptor antagonist.
    Wilson RJ; Giblin GM; Roomans S; Rhodes SA; Cartwright KA; Shield VJ; Brown J; Wise A; Chowdhury J; Pritchard S; Coote J; Noel LS; Kenakin T; Burns-Kurtis CL; Morrison V; Gray DW; Giles H
    Br J Pharmacol; 2006 Jun; 148(3):326-39. PubMed ID: 16604093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of BW A868C, a prostanoid DP-receptor antagonist, with two receptor subtypes in the rabbit isolated saphenous vein.
    Lydford SJ; McKechnie KC; Leff P
    Prostaglandins; 1996 Aug; 52(2):125-39. PubMed ID: 8880898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
    Meja KK; Barnes PJ; Giembycz MA
    Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
    Walch L; de Montpreville V; Brink C; Norel X
    Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel inhibitory prostanoid receptor in piglet saphenous vein.
    Coleman RA; Grix SP; Head SA; Louttit JB; Mallett A; Sheldrick RL
    Prostaglandins; 1994 Feb; 47(2):151-68. PubMed ID: 8016385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostanoid receptors involved in the relaxation of human pulmonary vessels.
    Walch L; Labat C; Gascard JP; de Montpreville V; Brink C; Norel X
    Br J Pharmacol; 1999 Feb; 126(4):859-66. PubMed ID: 10193765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and functional characterization of novel EP and DP receptor agonists: DP1 receptor mediates penile erection in multiple species.
    Brugger N; Kim NN; Araldi GL; Traish AM; Palmer SS
    J Sex Med; 2008 Feb; 5(2):344-56. PubMed ID: 18047485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of prostanoid IP and EP receptors in mediating vasorelaxant responses to PGI2 analogues in rat tail artery: Evidence for Gi/o modulation via EP3 receptors.
    Orie NN; Clapp LH
    Eur J Pharmacol; 2011 Mar; 654(3):258-65. PubMed ID: 21185823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory prostanoid EP receptors in human non-pregnant myometrium.
    Hillock CJ; Crankshaw DJ
    Eur J Pharmacol; 1999 Jul; 378(1):99-108. PubMed ID: 10478569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium.
    Cao J; Shayibuzhati M; Tajima T; Kitazawa T; Taneike T
    Eur J Pharmacol; 2002 May; 442(1-2):115-23. PubMed ID: 12020689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostanoid receptors involved in the relaxation of human bronchial preparations.
    Norel X; Walch L; Labat C; Gascard JP; Dulmet E; Brink C
    Br J Pharmacol; 1999 Feb; 126(4):867-72. PubMed ID: 10193766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the prostaglandin E2 sensitive (EP)-receptor in the rat isolated trachea.
    Lydford SJ; McKechnie K
    Br J Pharmacol; 1994 May; 112(1):133-6. PubMed ID: 8032634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostanoid-induced relaxation of precontracted cat ciliary muscle is mediated by EP2 and DP receptors.
    Chen J; Woodward DF
    Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3195-201. PubMed ID: 1328113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
    Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
    Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGE(2) receptor (EP(4)) agonists: potent dilators of human bronchi and future asthma therapy?
    Benyahia C; Gomez I; Kanyinda L; Boukais K; Danel C; Leséche G; Longrois D; Norel X
    Pulm Pharmacol Ther; 2012 Feb; 25(1):115-8. PubMed ID: 22244823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
    Kay LJ; Yeo WW; Peachell PT
    Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.